期刊文献+

AG1024对肝癌细胞系增殖与凋亡的影响 被引量:1

Effects of AG1024 on hepatocellular carcinoma cell lines
原文传递
导出
摘要 目的探讨胰岛素样生长因子Ⅰ型受体(IGF-IR)酪氨酸激酶阻断剂AG1024(3-溴-5-叔丁基-4-羟基苯叉苹果酸腈)对人肝癌癌细胞的增殖抑制作用和凋亡诱导作用。方法采用MTT、流式细胞术、细胞侵袭实验、RT—PCR和Westernblot等方法检测在不同浓度(0~40μmol/L)的AG1024作用下,人肝癌细胞系HepG2和SMMC-7721的细胞形态学及分子生物学特性的改变。结果MTT检测显示,AG1024剂量依赖性地抑制肝癌细胞的增殖。流式细胞术提示,AG1024明显促进肝癌细胞的凋亡。Transwell小室侵袭实验显示,AG1024能明显抑制肝癌细胞系HepG2和SMMC-7721的侵袭能力,与对照组比较差异有统计学意义(P〈0.05)。RT—PCR结果显示,肝癌细胞中IGF—IR呈高表达,不同浓度AG1024作用后,剂量依赖性地增加细胞色素C的表达。Western blotting结果显示,AG1024降低胞外途径信号调节激酶(extracellular signal—regulated kinase,ERK)的磷酸化水平,下调procaspase-3的表达,而总ERK保持不变。结论AG1024阻断胰岛素样生长因子1型受体,从而阻断其下游的信号传导途径,抑制肝癌细胞的增生,诱导凋亡。 Objective Tyrphostin AG1024 (3-Bromo-5-t-butyl-4-hydroxybenzylidenemalonitrile) is a specific insulin like growth factor type I receptor tyrosine kinase blocker, this study is to investigate the effect of AG1024 on the proliferation and apoptosis of hepatoeellular carcinoma cell lines. Methods Treated with AG1024 on varied concentrations (0 - 40 μmoL/L), human hepatocellular carcinoma cell lines HepG2 and SMMC-7721 were observed for morphological and molecular biology changes, the effect of AG1024 on the cell lines proliferation invasion ability as well as apoptosis was evaluated. Results MTT showed that AG1024 dose-dependently inhibited the proliferation of hepatocellular carcinoma cells, flow eytometry suggested that AG1024 significantly promoted cell lines apoptosis, the cell invasion assay indicated that AG1024 significantly inhibited cell's invasion ability. RT-PCR showed over-expression of IGF-IR in liver cancer cells, and AG1024 dose-dependently increased the expression of cytochrome C. According to the results of Western blotting, the phosphor-ERK and procaspase-3 were down-regulated while the total ERK remained unchanged. Conclusion AG1024 as a specific IGF-IR blocker blocks the downstream signaling cascade and thus inhibits the proliferation of hepatocellular carcinoma cells and induces cell's apoptosis.
出处 《中华普通外科杂志》 CSCD 北大核心 2008年第9期710-712,共3页 Chinese Journal of General Surgery
基金 浙江省科技厅科研资金资助项目(2005C23037)
关键词 肝细胞 细胞凋亡 受体 IGF1型 酶抑制剂 Carcinoma, hepatocellular Apoptosis Receptor IGF type 1 Enzyme inhibitors
  • 相关文献

参考文献1

二级参考文献45

  • 1[1]Weitz J,Koch M,Debus J,Hohler T,Galle PR,Buchler MW.Colorectal cancer.Lancet 2005; 365:153-165
  • 2[2]Rougier P,Mitry E.Epidemiology,treatment and chemoprevention in colorectal cancer.Ann Oncol 2003; 14Suppl 2:ii3-5
  • 3[3]Larsson O,Girnita A,Girnita L.Role of insulin-like growth factor 1 receptor signalling in cancer.Br J Cancer 2005; 92:2097-2101
  • 4[4]Hakam A,Yeatman TJ,Lu L,Mora L,Marcet G,Nicosia SV,Karl RC,Coppola D.Expression of insulin-like growth factor-1 receptor in human colorectal cancer.Hum Pathol 1999; 30:1128-1133
  • 5[5]Weber MM,Fottner C,Liu SB,Jung MC,Engelhardt D,Baretton GB.Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.Cancer 2002; 95:2086-2095
  • 6[6]Ullrich A,Schlessinger J.Signal transduction by receptors with tyrosine kinase activity.Cell 1990; 61:203-212
  • 7[7]van der Geer P,Hunter T,Lindberg RA.Receptor proteintyrosine kinases and their signal transduction pathways.Annu Rev Cell Biol 1994; 10:251-337
  • 8[8]Wang Y,Sun Y.Insulin-like growth factor receptor-1 as an anti-cancer target:blocking transformation and inducing apoptosis.Curr Cancer Drug Targets 2002; 2:191-207
  • 9[9]Baserga R.The contradictions of the insulin-like growth factor 1 receptor.Oncogene 2000; 19:5574-5581
  • 10[10]Schoen RE,Weissfeld JL,Kuller LH,Thaete FL,Evans RW,Hayes RB,Rosen CJ.Insulin-like growth factor-Ⅰ and insulin are associated with the presence and advancement of adenomatous polyps.Gastroenterology 2005; 129:464-475

共引文献9

同被引文献12

  • 1BASERGA R. The insulin like growth factor - 1 receptor ( IGF - 1R) as a drug target: novel approaches to cancer therapy [ J]. Growth Horm IGF Res, 2004, 14(4) : 287 -295.
  • 2李萍,章青,孙宜,等.EGFR和IGF-1R双路径阻断对乳腺癌细胞的协同放射增敏作用[C].中华医学会放射肿瘤治疗分会六届二次暨中国抗癌歇会肿瘤放疗专业委员会二届二次学术会议论文集,2009.
  • 3BENTZEN S M, ATASOY B M, DALEY F M, et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a bendfit from accelerated radiation therapy in a randomized con- trolled trial[J]. J Clin Oncol, 2005, 23(24) : 5437 -5439.
  • 4BEDZIO A, WYNES M W, DZIADZIUSZKO R, et al. Increased insulin - like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer[J]. J Thorac Oneol, 2010, 5(12) : 1905 -1911.
  • 5MEHRA R, SEP, EBPdlSKII I G, DUNBRACK R L, et al. Prot&n - intrinsic and signaling network - based sources of resistance to EG- FR - and ErbB family - targeted therapies in head and neck cancer [J]. Drug Resist Updat, 2011, 14(6) : 260 -279.
  • 6JUN H, CHANG M, KO Y, et al. Clinical significance of insulin - like growth factor type 1 receptor and epidermal growth factor re- ceptor in patients with advanced gastric cancer [ J]. Oncology, 2008, 74(1/2) : 76-83.
  • 7FUKUDA S, PELUS L M. Survivin - a cancer target with an emer- ging role in normal adult tissues[ J]. Mol Cancer Ther, 2006, 5 (5) : 1087 - 1098.
  • 8尹述成,周绪红,彭涛,李俊,江孝清.胰岛素样生长因子-1受体蛋白在鼻咽癌细胞中的表达及其临床意义[J].临床耳鼻咽喉头颈外科杂志,2008,22(19):874-877. 被引量:8
  • 9雷迅,向秋,王建红,范才文,黄岚珍,曾攀,肖胜军.SiRNA-Survivin增强鼻咽癌细胞对放射敏感性的实验研究[J].中国现代医学杂志,2009,19(23):3564-3567. 被引量:6
  • 10程金建,杨华,陈甲信,陆合明,陈华生,莫颖,黄翌航.调强放疗及化疗对鼻咽癌患者营养状况的影响[J].广东医学,2011,32(17):2336-2338. 被引量:27

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部